App

In a recent announcement, the Food and Drug Administration granted approval for Moderna’s vaccine for respiratory syncytial virus (RSV) for adults aged 60 and older. This marks a significant milestone for Moderna, as it diversifies its product portfolio beyond its Covid jab, which has seen a decrease in demand. The decision to approve Moderna’s RSV
0 Comments
The Municipal Bond market experienced a surge in issuance in May, surpassing $40 billion for the first time since 2016. The current volume of $43.957 billion in 866 issues represents a significant increase of 46.9% from the previous year. This surge in issuance can be attributed to several factors, including Federal Reserve policy uncertainty, pent-up
0 Comments
Investors have been riding high on the semiconductor sector in recent years, enjoying substantial returns on their investments. However, there are signs that a downturn may be on the horizon. With Nvidia (NVDA) showing signs of potential profit-taking after its post-earnings surge, it might be time for investors to consider hedging against further downside in
0 Comments
UBS recently released a list of its highest-conviction energy picks for the remainder of the year. Analyst Josh Silverstein highlighted the firm’s top buy-rated stocks in the energy and utilities sectors, including companies like Suncor Energy, Coterra Energy, SLB, NextEra Energy, and First Solar. These picks are based on the current market trends and potential
0 Comments
When Paul Lester ventured into the realm of luxury real estate in Los Angeles, he revolutionized the traditional property viewing experience. By seamlessly blending the worlds of art and real estate, Lester orchestrated an innovative approach that captivated prospective buyers. Transforming a Beverly Hills property viewing into an art opening, Lester curated a collection of
0 Comments
Baird recently initiated UnitedHealth as outperform, citing the health insurance company as a favorite idea at the firm. The firm views UnitedHealth Group as the most vertically and horizontally integrated Managed Care company, with a $597 price target indicating a potential 20% upside. Evercore ISI upgraded Okta to outperform from in line after the identity
0 Comments